Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway

Wen Zou, Xi Wang, Xiaomeng Xia, Tingting Zhang, Meifang Nie, Jing Xiong, Xiaoling Fang
Biochemical and biophysical research communications · 2023 · vol. 692 , pp. 149338 · doi:10.1016/j.bbrc.2023.149338 · PMID:38043156 · W4389101133
article OA: closed CC0 ⤵ 23 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Resveratrol protected against endometriosis development by promoting ferroptosis via the miR-21-3p/p53/SLC7A11 signaling pathway.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Ferroptosis Ferroptosis Ferroptosis Ferroptosis MicroRNAs MicroRNAs MicroRNAs MicroRNAs MicroRNAs Amino Acid Transport System y+ Amino Acid Transport System y+ Amino Acid Transport System y+ Amino Acid Transport System y+ Amino Acid Transport System y+ Animals

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (63)

Cited by (23)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-17T00:33:07.253553+00:00
unpaywall
last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0 · commercial use OK